We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLIBK:NASDAQGCI Liberty, Inc. - Series C GCI Group Analysis

Data as of 2026-06-13 - not real-time

$22.66

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Liberty Capital’s stock is currently trading below its short‑term moving averages, with momentum indicators showing a modestly bullish MACD histogram yet an RSI lingering in the lower‑mid range, suggesting limited upside momentum. The price sits near a recently identified support level while the broader trend remains bearish, and volatility is markedly high, though the beta indicates limited correlation with the broader market. Volume trends are improving, providing some liquidity cushion despite the company’s modest market capitalization.
Fundamentally, the firm reports declining revenue and negative profitability, but its cash position remains solid and free cash flow is positive, offering a buffer against earnings weakness. A discounted cash‑flow model places intrinsic value modestly above the current price, and the low price‑to‑book multiple reinforces an undervalued perception. The recent corporate name change is a neutral event with no immediate operational impact. Overall, the stock presents a value‑oriented opportunity with heightened short‑term risk, warranting cautious positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • high short‑term volatility
  • bullish MACD histogram but overall bearish trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • intrinsic value above market price
  • low price‑to‑book multiple
  • improving volume and solid cash position

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • persistent revenue decline and negative margins
  • stable regulatory environment for telecom services
  • absence of dividend and reliance on operational turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth-3.80%
Profit Margin-31.47%
ROE-20.41%
ROA2.86%
Debt/Equity60.35
P/B Ratio0.5
Op. Cash Flow$329.0M
Free Cash Flow$115.8M
Industry P/E17.0

Technical Analysis

TrendBearish
RSI39.6
Support$20.33
Resistance$26.23
MA 20$22.86
MA 50$29.53
MA 200$34.65
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$23.13
GradeUndervalued
TypeValue

Risk Assessment

Beta0.35
Volatility76.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.